Comparison of the Efficacy and Satisfaction of Blood Glucose Management Between Continuous Glucose Monitoring Versus Traditional Self-blood Glucose Measurement in Diabetic Patients After Pancreatectomy

Comparison of the Efficacy and Satisfaction of Blood Glucose Management Between Continuous Glucose Monitoring Versus Traditional Self-blood Glucose Measurement in Diabetic Patients After Pancreatectomy : A Randomized Controlled Open Labeled Trial

Status

Recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05149625

Enrollment

172

Registered

2021-12-08

Start date

2022-11-27

Completion date

2026-12-31

Last updated

2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Brief summary

This study aims to compare the efficacy and satisfaction of blood glucose management between continuous glucose monitoring versus traditional self blood glucose measurement in diabetic patients after pancreatectomy.

Detailed description

Patients will be enrolled after the 75g oral glucose tolerance test performed 7 days after pancreatectomy. Patients will be divided into two groups by randomization (continuous glucose measurement method vs. traditional self blood glucose measurement method), and 3months after surgery, HbA1c, hypoglycemic events, and satisfaction would be compared.

Interventions

DEVICEDexcom G6

continuous glucose monitoring device

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

19 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Patients over 19 years of age * Preoperative diabetes history * Patients who underwent subtotal or total pancreatectomy * Patients who were diagnosed with diabetes mellitus in the evaluation of endocrine function test on the 7th day after pancreaticoduodenectomy, central pancreatectomy, or distal pancreatectomy

Exclusion criteria

* Patients who have used continuous blood glucose measurement device more than once before. * Elderly patients who are not accustomed to using the smartphone applications * Serious systemic diseases that can affect diabetes (chronic kidney disease, heart failure, decompensated liver cirrhosis, etc.) * Steroid user during the study period * Major medical or psychiatric condition that will affect response to treatment

Design outcomes

Primary

Measure	Time frame
Hemoglobin A1c (HbA1c)	postoperative 3months

Secondary

Measure	Time frame
Hypoglycemic events	postoperative 3months
satisfaction survey	postoperative 3months
Fasting, postprandial plasma glucose	postoperative 3months

Countries

South Korea

Contacts

Primary ContactJin-Young Jang, Dr

jangjy4@gmail.com+82-02-2072-2194

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026